Last reviewed · How we verify

Tagrisso — Competitive Intelligence Brief

Tagrisso (Tagrisso) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology.

marketed Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma, Cysteine--tRNA ligase, cytoplasmic, Dipeptidyl peptidase 1 Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Tagrisso (Tagrisso) — Suzhou Genhouse Bio Co., Ltd..

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Tagrisso TARGET Tagrisso Suzhou Genhouse Bio Co., Ltd. marketed Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma, Cysteine--tRNA ligase, cytoplasmic, Dipeptidyl peptidase 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tagrisso — Competitive Intelligence Brief. https://druglandscape.com/ci/tagrisso. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: